Gastrointestinal Cancer

Top Story

Organized colorectal cancer screening program significantly increases screening rates

Organized colorectal cancer screening program significantly increases screening rates
September 20, 2018

Read the Perspective from Darrell Gray, II, MD, MPH

In the Journals

Recalled valsartan products may not increase cancer risk

September 19, 2018
Valsartan products that were contaminated with N-nitrosodimethylamine, an impurity that has been classified as a probable human carcinogen that led to recalls of several…
In the Journals

Tailoring FIT positivity threshold by age, sex may maximize colorectal cancer screening

September 17, 2018
At the conventional fecal immunochemical test positivity threshold, programmatic sensitivity for detection of colorectal cancer decreased as age increased and was higher…
In the Journals Plus

Anti-inflammatory may improve colon cancer surgery outcomes

September 17, 2018
The anti-inflammatory and anti-neoplastic agent taurolidine significantly decreased IL-6 levels in patients undergoing colon cancer surgery, potentially improving…
More Headlines »
CME

Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates

This activity is supported by an educational grant from Aries Pharmaceuticals Inc.

Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the…
More »
Video
Meeting News

Severe diarrhea an important side effect of checkpoint inhibitor cancer therapy

June 14, 2018
More »
Resource Centers
Immuno-Oncology Resource Center

Immuno-Oncology Resource Center

CME

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

This educational activity is supported by an independent medical educational grant from Merck & Co., Inc.

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis…
More »